Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 28-10-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Replimune Group, Inc.- Registered Equity Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Cravath represented the underwriters, led by J.P. Morgan Securities, SVB Leerink and Barclays, in connection with the USD287.5 million registered equity offering of Replimune Group, Inc., a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform. The offering consisted of shares of Replimune's common stock and pre‑funded warrants to acquire shares of its common stock. The shares were listed on The Nasdaq Global Select Market.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Cravath |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Johnny G Skumpija |
